225 related articles for article (PubMed ID: 20921419)
1. Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected].
Ding H; Inoue S; Ljubimov AV; Patil R; Portilla-Arias J; Hu J; Konda B; Wawrowsky KA; Fujita M; Karabalin N; Sasaki T; Black KL; Holler E; Ljubimova JY
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18143-8. PubMed ID: 20921419
[TBL] [Abstract][Full Text] [Related]
2. Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.
Inoue S; Ding H; Portilla-Arias J; Hu J; Konda B; Fujita M; Espinoza A; Suhane S; Riley M; Gates M; Patil R; Penichet ML; Ljubimov AV; Black KL; Holler E; Ljubimova JY
Cancer Res; 2011 Feb; 71(4):1454-64. PubMed ID: 21303974
[TBL] [Abstract][Full Text] [Related]
3. Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer.
Ding H; Helguera G; Rodríguez JA; Markman J; Luria-Pérez R; Gangalum P; Portilla-Arias J; Inoue S; Daniels-Wells TR; Black K; Holler E; Penichet ML; Ljubimova JY
J Control Release; 2013 Nov; 171(3):322-9. PubMed ID: 23770212
[TBL] [Abstract][Full Text] [Related]
4. Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer.
Inoue S; Patil R; Portilla-Arias J; Ding H; Konda B; Espinoza A; Mongayt D; Markman JL; Elramsisy A; Phillips HW; Black KL; Holler E; Ljubimova JY
PLoS One; 2012; 7(2):e31070. PubMed ID: 22355336
[TBL] [Abstract][Full Text] [Related]
5. A Combination of Tri-Leucine and Angiopep-2 Drives a Polyanionic Polymalic Acid Nanodrug Platform Across the Blood-Brain Barrier.
Israel LL; Braubach O; Galstyan A; Chiechi A; Shatalova ES; Grodzinski Z; Ding H; Black KL; Ljubimova JY; Holler E
ACS Nano; 2019 Feb; 13(2):1253-1271. PubMed ID: 30633492
[TBL] [Abstract][Full Text] [Related]
6. Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery.
Lee BS; Fujita M; Khazenzon NM; Wawrowsky KA; Wachsmann-Hogiu S; Farkas DL; Black KL; Ljubimova JY; Holler E
Bioconjug Chem; 2006; 17(2):317-26. PubMed ID: 16536461
[TBL] [Abstract][Full Text] [Related]
7. Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).
Fujita M; Lee BS; Khazenzon NM; Penichet ML; Wawrowsky KA; Patil R; Ding H; Holler E; Black KL; Ljubimova JY
J Control Release; 2007 Oct; 122(3):356-63. PubMed ID: 17630012
[TBL] [Abstract][Full Text] [Related]
8. Nanoconjugate based on polymalic acid for tumor targeting.
Ljubimova JY; Fujita M; Khazenzon NM; Lee BS; Wachsmann-Hogiu S; Farkas DL; Black KL; Holler E
Chem Biol Interact; 2008 Jan; 171(2):195-203. PubMed ID: 17376417
[TBL] [Abstract][Full Text] [Related]
9. Dual-pH Sensitive Charge-reversal Nanocomplex for Tumor-targeted Drug Delivery with Enhanced Anticancer Activity.
Zhou Q; Hou Y; Zhang L; Wang J; Qiao Y; Guo S; Fan L; Yang T; Zhu L; Wu H
Theranostics; 2017; 7(7):1806-1819. PubMed ID: 28638469
[TBL] [Abstract][Full Text] [Related]
10. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
[TBL] [Abstract][Full Text] [Related]
11. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment.
Jiang X; Xin H; Ren Q; Gu J; Zhu L; Du F; Feng C; Xie Y; Sha X; Fang X
Biomaterials; 2014 Jan; 35(1):518-29. PubMed ID: 24125772
[TBL] [Abstract][Full Text] [Related]
13. Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.
Ljubimova JY; Fujita M; Ljubimov AV; Torchilin VP; Black KL; Holler E
Nanomedicine (Lond); 2008 Apr; 3(2):247-65. PubMed ID: 18373429
[TBL] [Abstract][Full Text] [Related]
14. Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas.
Fornaguera C; Lázaro MÁ; Brugada-Vilà P; Porcar I; Morera I; Guerra-Rebollo M; Garrido C; Rubio N; Blanco J; Cascante A; Borrós S
Drug Deliv; 2018 Nov; 25(1):472-483. PubMed ID: 29412012
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis.
Fujita M; Khazenzon NM; Ljubimov AV; Lee BS; Virtanen I; Holler E; Black KL; Ljubimova JY
Angiogenesis; 2006; 9(4):183-91. PubMed ID: 17109197
[TBL] [Abstract][Full Text] [Related]
16. Salvianolic acid A increases the accumulation of doxorubicin in brain tumors through Caveolae endocytosis.
Zhang C; Pan Y; Cai R; Guo S; Zhang X; Xue Y; Wang J; Huang J; Wang J; Gu Y; Zhang Z
Neuropharmacology; 2020 May; 167():107980. PubMed ID: 32014448
[TBL] [Abstract][Full Text] [Related]
17. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
18. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
19. Acid-Induced Activated Cell-Penetrating Peptide-Modified Cholesterol-Conjugated Polyoxyethylene Sorbitol Oleate Mixed Micelles for pH-Triggered Drug Release and Efficient Brain Tumor Targeting Based on a Charge Reversal Mechanism.
Tian Y; Mi G; Chen Q; Chaurasiya B; Li Y; Shi D; Zhang Y; Webster TJ; Sun C; Shen Y
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43411-43428. PubMed ID: 30508486
[TBL] [Abstract][Full Text] [Related]
20. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
Yuan X; Dillehay LE; Williams JR; Williams JA
Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
